How severe is CVE-2025-3423?

CVE-2025-3423 has a CVSS 3.x base score of 5.4, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.

Is CVE-2025-3423 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (15th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2025-3423?

CVE-2025-3423 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2025-3423?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2025-3423 have an EU (EUVD) identifier?

Yes. CVE-2025-3423 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-10850.

When was CVE-2025-3423 published?

CVE-2025-3423 was published on 2025-04-13 and last updated on 2026-06-17.

CVE-2025-3423

CVE-2025-3423 is a medium-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 5.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Medium (CVSS 3.x base score 5.4)
EPSS exploit prediction: 0% (15th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2025-10850
Weakness: CWE-79
Affected product: Ibm Aspera Faspex
Published: 2025-04-13
Last modified: 2026-06-17

Description

IBM Aspera Faspex 5.0.0 through 5.0.11 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Frequently asked questions

What is CVE-2025-3423?: IBM Aspera Faspex 5.0.0 through 5.0.11 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
How severe is CVE-2025-3423?: CVE-2025-3423 has a CVSS 3.x base score of 5.4, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2025-3423 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (15th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-3423?: CVE-2025-3423 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-3423?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-3423 have an EU (EUVD) identifier?: Yes. CVE-2025-3423 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-10850.
When was CVE-2025-3423 published?: CVE-2025-3423 was published on 2025-04-13 and last updated on 2026-06-17.

References

https://www.ibm.com/support/pages/node/7230757

Affected products (1)

cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:*

More vulnerabilities in Ibm Aspera Faspex

CVE-2023-27874 — Critical (CVSS 9.9): IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A…
CVE-2022-47986 — Critical (CVSS 9.8): IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the…
CVE-2023-37400 — High (CVSS 7.8): IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential…
CVE-2023-30995 — High (CVSS 7.5): IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist…
CVE-2023-27871 — High (CVSS 7.5): IBM Aspera Faspex 4.4.2 could allow a remote attacker to obtain sensitive credential information for an external user,…
CVE-2023-27875 — High (CVSS 7.5): IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. IBM…

All CVEs affecting Ibm Aspera Faspex →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →